(CercleFinance.com) – Sanofi indicates that it is increasing its investments by 1.1 billion euros in its major industrial projects in France, to create new bioproduction capacities on its sites in Vitry-sur-Seine (Val de Marne), Le Trait (Seine-Maritime) and Lyon Gerland (Rhône).
‘This new investment will enable the creation of more than 500 jobs and will significantly strengthen France’s capacity to control the end-to-end production of current and future essential medicines’, underlines the health giant.
In total, since the Covid-19 pandemic, Sanofi has deployed an investment plan of more than 3.5 billion euros to finance its major drug and vaccine production projects in France, for patients around the world. ‘.